Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | MYC | P01106 | 1/20 | 0.40 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.39 |
| ▸ | FEN1 | P39748 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.36 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.36 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3644471 | 1.00 | HPGD (0.40) | HPGDMYCERCC5FEN1KMT2A | |
| SCHEMBL1443195 | 1.00 | HPGD (0.40) | HPGDMYCERCC5FEN1KMT2A | |
| SCHEMBL29869399 | 1.00 | HPGD (0.40) | HPGDMYCERCC5FEN1KMT2A | |
| SCHEMBL22639010 | 0.88 | MYC (0.38) | HPGDMYCKMT2AKDM4EALDH1A1 | |
| SCHEMBL30122149 | 0.88 | MYC (0.38) | HPGDMYCKMT2AKDM4EALDH1A1 | |
| Water SCHEMBL23070689 | 0.86 | MYC (0.37) | HPGDMYCKMT2AKDM4EALDH1A1 | |
| SCHEMBL28127994 | 0.81 | ALDH1A1 (0.47) | HPGDERCC5FEN1ADRB2ADRB1 | |
| SCHEMBL28195204 | 0.81 | CES2 (0.44) | HPGDERCC5FEN1KMT2AADRB2 | |
| SCHEMBL7181728 | 0.80 | HPGD (0.43) | HPGDKMT2AKDM4EALDH1A1HSD17B10 | |
| SCHEMBL2722029 | 0.80 | HPGD (0.43) | HPGDKMT2AKDM4EALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3419974-B1 | PROCESS FOR THE SEPARATION OF ENANTIOMERS OF PIPERAZINE DERIVATIVES | ASCENEURON SA (CH) | 2021-05-05 | — | — | EP | claimed |
| CN-109462982-A | Dimension Doreptide under physiological condition with poor solubility is for treating acromegalia, acromegalia cancer, SST-R5 expression type tumour, type-2 diabetes mellitus, hyperglycemia and hormone related neoplasms | 斯特朗布里奇都柏林有限公司 | 2019-03-12 | — | — | CN | claimed |
| EP-3286168-A1 | A SOLID FORM OF APREMILAST AND A PROCESS FOR PREPARING THE SAME | Zentiva K.S. (CZ) | 2018-02-28 | — | — | EP | claimed |
| WO-2016169533-A1 | A SOLID FORM OF APREMILAST AND A PROCESS FOR PREPARING THE SAME | ZENTIVA, K.S. (CZ) | 2016-10-27 | — | — | WO | claimed |
| EP-2588441-A2 | NOVEL PROCESSES FOR THE PREPARATION OF PHENYLCYCLOPROPYLAMINE DERIVATIVES AND USE THEREOF FOR PREPARING TICAGRELOR | Actavis Group Ptc Ehf (IS) | 2013-05-08 | — | — | EP | claimed |
| WO-2012001531-A2 | NOVEL PROCESSES FOR THE PREPARATION OF PHENYLCYCLOPROPYLAMINE DERIVATIVES AND USE THEREOF FOR PREPARING TICAGRELOR | ACTAVIS GROUP PTC EHF (IS) | 2012-01-05 | — | — | WO | claimed |
| EP-2118061-A2 | PROCESS OF ENANTIOMERIC RESOLUTION OF D,L-( + )-THREO-METHYLPHENIDATE | Archimica, Inc. (US) | 2009-11-18 | — | — | EP | claimed |
| WO-2008125914-A2 | PROCESS OF ENANTIOMERIC RESOLUTION OF D,L-( + )-THREO-METHYLPHENIDATE | ARCHIMICA, INC. (US) | 2008-10-23 | — | — | WO | claimed |
| EP-1802628-A1 | CRYSTALLINE FORMS AND PROCESS FOR PREPARING SPIRO-HYDANTOIN COMPOUNDS | Bristol-Myers Squibb Company (US) | 2007-07-04 | — | — | EP | claimed |
| WO-2006039639-A1 | CRYSTALLINE FORMS AND PROCESS FOR PREPARING SPIRO-HYDANTOIN COMPOUNDS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2006-04-13 | — | — | WO | claimed |
| WO-2004065375-A1 | PROCESSES FOR THE PREPARATION OF ESCITALOPRAM AND ITS PRECURSOR | NATCO PHARMA LIMITED (IN) | 2004-08-05 | — | — | WO | claimed |
| EP-0759904-A1 | PROCESS AND DIASTEREOMERIC SALTS USEFUL FOR THE OPTICAL RESOLUTION OF RACEMIC ALPHA-[4-(1,1-DIMETHYLETHYL)PHENYL]-4-(HYDROXYDIPHENYLMETHYL)-1-PIPERIDINEBUTANOL AND DERIVATIVE COMPOUNDS | MERRELL PHARMACEUTICALS INC. (US) | 1997-03-05 | — | — | EP | claimed |
| WO-1995031436-A1 | PROCESS AND DIASTEREOMERIC SALTS USEFUL FOR THE OPTICAL RESOLUTION OF RACEMIC α-[4-(1,1-DIMETHYLETHYL)PHENYL]-4-(HYDROXYDIPHENYLMETHYL)-1-PIPERIDINEBUTANOL AND DERIVATIVE COMPOUNDS | MERRELL PHARMACEUTICALS INC. (US) | 1995-11-23 | — | — | WO | claimed |
| WO-1992014729-A1 | ANTIVIRAL 1,3-DIOXOLANE NUCLEOSIDES AND SYNTHESIS THEREOF | EMORY UNIVERSITY (US) | 1992-09-03 | — | — | WO | claimed |
| JP-10226678-A | — | — | None | — | — | JP | disclosed |
| CN-115054600-B | Aromatic sulfonamide derivatives | 拜耳制药股份公司 | 2024-06-14 | — | — | CN | disclosed |
| EP-4259633-A1 | PROCESSES FOR THE PREPARATION OF ZANUBRUTINIB AND INTERMEDIATES THEREOF | Teva Pharmaceuticals International GmbH (CH) | 2023-10-18 | — | — | EP | disclosed |
| WO-1995031436-A1 | PROCESS AND DIASTEREOMERIC SALTS USEFUL FOR THE OPTICAL RESOLUTION OF RACEMIC α-[4-(1,1-DIMETHYLETHYL)PHENYL]-4-(HYDROXYDIPHENYLMETHYL)-1-PIPERIDINEBUTANOL AND DERIVATIVE COMPOUNDS | MERRELL PHARMACEUTICALS INC. (US) | 1995-11-23 | — | — | WO | disclosed |
| EP-0575482-A1 | ANTIVIRAL ACTIVITY AND RESOLUTION OF 2-HYDROXYMETHYL-5-(5-FLUOROCYTOSIN-1-YL)-1,3-OXATHIOLANE | EMORY UNIVERSITY (US) | 1993-12-29 | — | — | EP | disclosed |
| WO-1992014743-A2 | ANTIVIRAL ACTIVITY AND RESOLUTION OF 2-HYDROXYMETHYL-5-(5-FLUOROCYTOSIN-1-YL)-1,3-OXATHIOLANE | EMORY UNIVERSITY (US) | 1992-09-03 | — | — | WO | disclosed |